eHV Advanced LP (eHealth Ventures II)

www.ehv.health

Venture Capital Fund

Final Closing

Tech Verticals Preferences

Artificial Intelligence, Big Data, BioConvergence, Biotechnology, Diagnostics, Digital Health, eHealth, Healthtech, Homecare, IoT, Machine Learning, MedTech, Software Technologies, Telemedicine

General Data

Management Company:	eHealth Ventures (eHV) Advanced
Vintage Year	2022
Current Active Portfolio Companies:	27
Reg. Number:	abCDe

DESCRIPTION

The eHealth Ventures partnership is a leading investor in early-stage digital health companies. It includes 2 VC funds and a technological incubator with an exclusive focus on digital health and significant government non-dilutive funding. Partners include Maccabi (a leading Israeli HMO), Amgen (global biotech giant), the Mayo Clinic, Medison Ventures, Arad Investments, and the Hadar Group. The team has reviewed over 1,700 companies to date and invested in a portfolio of 24 highly innovative companies (digital diagnostics, therapeutics, home care and Bioconvergence).

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	2 Koifman St.
City	Tel Aviv
Country	Israel
Zip	6801294

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Talor Sax	Founding Partner	Ewave MD (VP, Business Development)

	CAPITAL RAISED

Date

Amount

Jan. 01, 2022

abCDe

Limited Partners	Type	Amount	Remarks
abC Defghij*	Corporate VC	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Other	abCDe
abC Defghij	Other	abCDe
abC Defghij	N/A	abCDe

Investment Data

Managed Capital	abCDe
Capital Remarks	A follow on Micro Fund.

Preferences

Maximum investments	$3m
Minimum investments	$0.5m
Type of Financing	Equity
Stage Preferences	R&D,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Digital Health

77%

Medical Devices

19%

Biomed

	PORTFOLIO COMPANIES

Current Portfolio Companies (27)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

AccuLine

Dig. Health

First Round

01/05/2024

N/A

$3.5m

Agamon Health

Dig. Health

First Round - Extended

08/11/2022

N/A

$2m

DermaDetect

Dig. Health

First Round

09/09/2021

N/A

$2.15m

DreaMed

Dig. Health

Second Round

19/08/2024

N/A

$3m

EFA

EfA’s product: RevDx (Revolutionary Diagnostics) is a mobile, portable, handheld, end-point solution that includes an innovative method to perform an automatic computerized microscopy like inspection, including a whole blood sampling and an automatic diagnosis of blood count and other applications to be followed. The product is an easy-to-operate, based on a finger prick and without the need for laboratory conditions and specific preparations. For example, you will be able to make a real-time informed decision about the unnecessary use of antibiotic treatment and the necessity of continued clarification. This product will be an essential device for every point-of-need around the world.

Dig. Health

First Round - Extended	28/01/2024	N/A	N/A
First Round - Extended	05/01/2022	$1m	$3.65m

Fize Medical

Second Round

23/12/2024

N/A

$14m

GaitBetter

Dig. Health

Seed - Extended

01/10/2022

$0.85m

IdentifAI

Biomed

Seed - Extended	25/07/2025	N/A	N/A
Seed - Extended	25/01/2023	N/A	$3.3m

InhaliMed

Dig. Health

Seed

01/11/2024

N/A

$0.85m

Insight Axis

Dig. Health

Seed

01/01/2024

$0.85m

$1.75m

Nervio

Dig. Health

First Round	01/09/2023	N/A	$0.5m
Seed - Extended	01/01/2022	$0.49m	$0.49m

NimBio

Dig. Health

Seed - Extended

01/11/2022

N/A

Nitur

Dig. Health

Seed

01/02/2024

$0.85m

$1.75m

Olive Diagnostics

Dig. Health

First Round	03/05/2023	N/A	$3m
Seed - Extended	30/08/2022	N/A	$1.5m

OtiSense

OtiSence develops an innovative technology for accurate clinical diagnostic at home. The company's device is easy to use and accurate device that will improve way AOM is diagnosed.

Seed

01/01/2024

$0.85m

$1.75m

QLog

Dig. Health

Seed

01/08/2022

$1.5m

RespirAI Medical

Dig. Health

Seed	01/04/2025	N/A	N/A
Seed	01/03/2022	$0.1m	$1m

SleepAI

Dig. Health

Seed

01/12/2024

N/A

$0.85m

Smartest

Seed

01/06/2023

$0.15m

$0.8m

SurgiAI

Dig. Health

Seed

01/09/2024

$0.05m

$0.85m

Symetrify

Dig. Health

Seed

01/01/2022

N/A

$0.85m

ToDx

Seed

01/07/2023

$1m

N/A

TuneMe

Dig. Health

Seed

01/12/2023

$0.1m

$0.9m

Venobotic

VenoGuard develops an innovative platform for blood testing.

Seed

01/12/2024

$0.85m

VocaVibe

Dig. Health

Seed

01/06/2023

N/A

$0.9m

Wizermed

Dig. Health

Seed

01/02/2024

N/A

$0.85m

YonaLink

Dig. Health

Seed - Extended

08/11/2022

$1.5m

$6m

Historic Portfolio (3)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Ophthalmic Sciences

Ceased to Operate

Seed - Extended

01/01/2022

$0.4m

SpeakSuite

Ceased to Operate

Dig. Health

Seed - Extended

01/02/2021

N/A

$1.5m

TrainPain

Ceased to Operate

Dig. Health

Seed - Extended

16/02/2021

N/A

Last Updated:	abCDe
IVC Number:	abCDe